Clinical Trials Directory

Trials / Completed

CompletedNCT04781153

Bergen Oral Respiratory Intervention Study

The Impact of Oral Bacteria on Lung Function and Inflammation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
62 (actual)
Sponsor
Anders Røsland · Academic / Other
Sex
All
Age
25 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate if treatment of periodontitis (gum disease) in a relatively young and healthy population can improve lung function. It is hypothesized that removing the dental biofilm reduce the source of inflammatory bacteria that can reach the lungs, and thereby reduce lung inflammation and lead to improved lung function.

Detailed description

After being informed about the study and potential risks, all participants giving written informed consent will undergo a clinical screening to determine eligibility for study entry. The study participants will be randomized into two groups. Half of the study participants will after baseline move directly into an active periodontal treatment phase including oral hygiene instructions and professional tooth cleaning by a full mouth disinfection protocol (intervention 2). New data will be collected after 6-8 weeks of healing. The second study group will after baseline receive prophylactic periodontal treatment by oral hygiene instructions and supragingival plaque removal (intervention 1). New data will be collected after 3-4 weeks. This group will now receive the active periodontal treatment phase (intervention 2) like the first study had initially. New data will be collected after 6-8 weeks of healing. Both groups will receive supportive periodontal treatment every 3 months in 12 months after intervention 2.

Conditions

Interventions

TypeNameDescription
PROCEDUREPeriodontal treatmentPeriodontal treatment (scaling and rootplaning) with adjunctive chlorhexidine use

Timeline

Start date
2021-04-27
Primary completion
2024-06-27
Completion
2024-06-27
First posted
2021-03-04
Last updated
2025-02-06

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04781153. Inclusion in this directory is not an endorsement.